Cargando…
Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications
The mechanisms underlying the pathophysiology of severe psychiatric illnesses are complex, involving multiple neuronal and neurochemical pathways. A growing body of evidence indicates that alterations in hypothalamic–pituitary–adrenal (HPA) axis function may be a trait marker in both mood disorders...
Autores principales: | Gallagher, Peter, Young, Allan H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671735/ https://www.ncbi.nlm.nih.gov/pubmed/19412444 |
Ejemplares similares
-
A study evaluating the effect of mifepristone (RU-486) for the treatment of leiomyomata uteri
por: Mukherjee, Sucheta, et al.
Publicado: (2011) -
Determination of Mifepristone (RU-486) and Its Metabolites in Maternal Blood Sample after Pharmacological Abortion
por: Szpot, Paweł, et al.
Publicado: (2022) -
Mifepristone (RU486) inhibits dietary lipid digestion by antagonizing the role of glucocorticoid receptor on lipase transcription
por: Ma, Peng, et al.
Publicado: (2021) -
Mifepristone (RU-486(®)) as a Schedule IV Controlled Drug—Implications for a Misleading Drug Policy on Women’s Health Care
por: Hsieh, Yi-Ping, et al.
Publicado: (2022) -
The progesterone antagonist mifepristone/RU486 blocks the negative effect on life span caused by mating in female Drosophila
por: Landis, Gary N., et al.
Publicado: (2015)